Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The 3D Study: Deferiprone in Alzheimer's Disease
NCT03234686Phase 2Completed
- Sponsor
- Neuroscience Trials Australia
- Start
- Jan 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferiprone in Alzheimer's disease (AD), sponsored by Neuroscience Trials Australia. Started Jan 2018; status: completed.
02
Drugs
deferiprone
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03234686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03234686.